Navigation Links
NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007
Date:11/20/2007

LAWRENCE, Mass., Nov. 20 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will participate in the 19th Annual Piper Jaffray Healthcare Conference. Mr. Burbank is scheduled to present an overview of the Company at 2:30 p.m. Eastern Time on Tuesday, November 27, 2007 at The Pierre Hotel in New York City.

To listen to the audio web cast of the presentation during the event, please visit: http://www.nxstage.com and click on 'Investor Information'. A replay will be available for 30 days immediately following the live presentation.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "esti
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
2. NxStage Medical Provides Update on Medisystems Acquisition
3. NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
4. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. ATS Medical Expands Open Pivot Heart Valve Offerings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., SPRING VALLEY, Calif., Nov. 6 Ca...arded a Small Business Innovative Research (SBIR) ... and Material command. Under terms of the agreemen...ts (ASRs) for the diagnosis of Dengue virus. ,...t represents a major threat to military forces dep...
(Date:11/6/2009)..., HAYWARD, Calif., Nov. 6 Intarcia...day on its ITCA 650 (DUROS® continuous delive... 2 diabetes at the Ninth Annual Diabetes Technolog...://www.newscom.com/cgi-bin/prnh/20050301/SFTU126LO...xenatide Via ITCA 650 Lowers Plasma Glucose, HbA1c...
(Date:11/5/2009)... TRANSPORTATION -- Gone hybrid . . . , Fuel ec...les are now posted at the www.fueleconomy.gov we...ped and maintains for the U.S. Department of Energ...ne of the top 10 vehicles on the best fuel economy...s (51 MPG city; 48 highway). "This list proves tha...
(Date:11/5/2009)..., WELLINGTON, Colo., Nov. 5 The en...towns in the western U.S. This rare carnivore fee...sceptible to plague and often entire population di...fe Service (FWS) has implemented a ferret breeding...errets into their formerly native habitat. Unfort...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
...said it has partnered with Medical Numerics Inc. i...ic resonance imaging software product. , ,"Both of...clinical practice," said Doug Tucker, CEO of Neur... collaborate on our efforts to develop clinically ...linical community." , , Medical Numerics speciali...
...logy officials hope Froedtert Memorial Lutheran H...ntrepreneurial medical imaging company will be the...ting. , ,In the past, the state,s early-stage biot...he hope of gaining a long-term funding commitment,...eve they are more likely to curry favor with money...
...ications said it has received $285,000 in further...esting Network , which invested $445,000 in the ne...etwork drivers and other products for Apple,s Mac ...ense $3.4 million in funding has been allocated f...munications technology for the U.S. Army. , , More...
Other Biology Technology:Froedtert invests $1.5M in local medical imaging startup 2Froedtert invests $1.5M in local medical imaging startup 3
(Date:11/5/2009)... Conn.Researchers at Yale University have develope...y,s immune response to HIV and HIV-infected cells,...gs, published online in the Journal of the Americ...tic approaches for these diseases. , The molecu...g HIV" (ARM-H) and "antibody-recruiting molecule t...
(Date:11/4/2009)...fic corridors in the cities of Long Beach and Rive... of preventable childhood asthma, and the true imp...ease has likely been underestimated, according to ...ia (USC). , The study, which appears in an onli...th , estimated that nine percent of all childhood ...
(Date:11/4/2009)...sity of Oklahoma at Norman has received more than ...gencies as part of the federal stimulus program, b...ed by OU researchers to $23 million. Thirty-three...nging from archaeology to weather. , "The univer...oach to matching areasof scholarly excellence to f...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Drinking in Adolescence May Lead to Risky Choices Later 57868 1Drinking in Adolescence May Lead to Risky Choices Later 57868 2Drinking in Adolescence May Lead to Risky Choices Later 57868 3HealthCare Partners IPA Dr Richard Merkin CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9 11 57863 1HealthCare Partners IPA Dr Richard Merkin CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9 11 57863 2HealthCare Partners IPA Dr Richard Merkin CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9 11 57863 3Premier Members FCUs Rowe to Serve as March of Dimes March for Babies Chair 57859 1Premier Members FCUs Rowe to Serve as March of Dimes March for Babies Chair 57859 2
...ble permits are all the rage in environmental poli...e carbon emissions and improve air quality. A grou...therlands and Germany, are working together to fin... too. So far, it looks promising, but probably onl...ropean Commission expressed an interest in using t...
...bal analysis of the potential effect of climate ch...pacted by dams or extensive development will requi... ecosystems and people, according to an article pu...n Ecology and the Environment. , As a result of d...e experienced dramatic changes in flow, reducing t...
...uropean Commission has adopted an Integrated Marit...orlds largest maritime territory, marking the firs...ic approach to decision-making in Maritime Affairs... 10 October in Brussels, Belgium. , European Comm...rs Joe Borg said: "This is a crucial first step fo...
Other Biology News:Buying and selling habitats to help wildlife 2International team of scientists warns of climate change's impact on global river flow 2EC unveils new EU maritime policy 2EC unveils new EU maritime policy 3EC unveils new EU maritime policy 4
Rabbit Anti-Human Leucine-rich repeat-containing G-protein coupled receptor 4 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Mouse Anti-Human HLA Class II DQ1 7 Monoclonal Antibody, Unconjugated, Clone 4i144 from Abcam
Cultured Human Visceral (omental) preadipocytes from Zen-Bio, Inc.
Rabbit Anti-Human ADAM-12 (Meltrin alpha), carboxy terminal end Antibody, Unconjugated from CEDARLANE Laboratories Limited
Biology Products: